Addition of oxaliplatin to capecitabine-based preoperative chemoradiotherapy for locally advanced rectal cancer: Long-term outcome of a phase II study

Podobne zapisy

• Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer
  od: Lin, Junzhong, i wsp.
  Wydane: (2016)
• Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancer
  od: Peng, Jianhong, i wsp.
  Wydane: (2016)
• Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial
  od: Fulong Wang, i wsp.
  Wydane: (2018-12-01)
• Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial
  od: Wang, Fulong, i wsp.
  Wydane: (2018)
• Long-Term Outcome of Oxaliplatin and Capecitabine (XELOX) Concomitant with Neoadjuvant Radiotherapy and Extended to the Resting Period in High Risk Locally Advanced Rectal Cancer
  od: Tang, Jinghua, i wsp.
  Wydane: (2018)